Last reviewed · How we verify
combination of various doses of sildenefil and alprostadil — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
combination of various doses of sildenefil and alprostadil (combination of various doses of sildenefil and alprostadil) — Keogh Institute for Medical Research.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| combination of various doses of sildenefil and alprostadil TARGET | combination of various doses of sildenefil and alprostadil | Keogh Institute for Medical Research | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- combination of various doses of sildenefil and alprostadil CI watch — RSS
- combination of various doses of sildenefil and alprostadil CI watch — Atom
- combination of various doses of sildenefil and alprostadil CI watch — JSON
- combination of various doses of sildenefil and alprostadil alone — RSS
Cite this brief
Drug Landscape (2026). combination of various doses of sildenefil and alprostadil — Competitive Intelligence Brief. https://druglandscape.com/ci/combination-of-various-doses-of-sildenefil-and-alprostadil. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab